SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (30147)1/12/2000 3:09:00 PM
From: WTDEC  Respond to of 32384
 
Henry, I was unfortunately engaged in a brief side discussion when NHL was discussed and I only caught bits and pieces. ONTAK was discussed at length in that context and apparently is doing well. The goal is to have an alternative where patients on other therapies (Rituxan etc.)regress.

Hopefully medsunman will clarify the Targretin question.

Best regards,

Walter